These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 24205317)
21. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells. Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873 [TBL] [Abstract][Full Text] [Related]
22. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781 [TBL] [Abstract][Full Text] [Related]
23. Cerebral tissue hemoglobin saturation in children with sickle cell disease. Quinn CT; Dowling MM Pediatr Blood Cancer; 2012 Nov; 59(5):881-7. PubMed ID: 22678814 [TBL] [Abstract][Full Text] [Related]
24. Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. Mohan JS; Lip GY; Wright J; Bareford D; Blann AD Blood Coagul Fibrinolysis; 2005 Apr; 16(3):209-14. PubMed ID: 15795541 [TBL] [Abstract][Full Text] [Related]
25. Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease. Ataga KI; Hinderliter A; Brittain JE; Jones S; Xu H; Cai J; Kim S; Pritchard KA; Hillery CA Hematology; 2015 Jun; 20(5):289-96. PubMed ID: 24801127 [TBL] [Abstract][Full Text] [Related]
26. Silent infarcts in young children with sickle cell disease. Kwiatkowski JL; Zimmerman RA; Pollock AN; Seto W; Smith-Whitley K; Shults J; Blackwood-Chirchir A; Ohene-Frempong K Br J Haematol; 2009 Aug; 146(3):300-5. PubMed ID: 19500105 [TBL] [Abstract][Full Text] [Related]
27. Transcranial Doppler and brain MRI in children with sickle cell disease and high hemoglobin F levels. Asbeutah A; Gupta R; Al-Saeid O; Ashebu S; Al-Sharida S; Mullah-Ali A; Mustafa NY; Adekile A Pediatr Blood Cancer; 2014 Jan; 61(1):25-8. PubMed ID: 24038756 [TBL] [Abstract][Full Text] [Related]
28. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India. Nishank SS; Singh MP; Yadav R Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124 [TBL] [Abstract][Full Text] [Related]
29. Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Gallistl S; Sudi KM; Borkenstein M; Weinhandl G; Zotter H; Muntean W Blood Coagul Fibrinolysis; 2000 Dec; 11(8):755-60. PubMed ID: 11132654 [TBL] [Abstract][Full Text] [Related]
30. Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Setty BN; Key NS; Rao AK; Gayen-Betal S; Krishnan S; Dampier CD; Stuart MJ Br J Haematol; 2012 May; 157(3):370-80. PubMed ID: 22360627 [TBL] [Abstract][Full Text] [Related]
31. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia. Mourad H; Fadel W; El Batch M; Rowisha M Egypt J Immunol; 2008; 15(1):25-37. PubMed ID: 20306667 [TBL] [Abstract][Full Text] [Related]
32. ADAMTS-13-VWF axis in sickle cell disease patients. Ladeira VS; Barbosa AR; Oliveira MM; Ferreira LGR; de Oliveira Júnior WV; de Oliveira Renó C; Reis EA; Chaves DG; Dusse LMS; Dos Santos HL; de Barros Pinheiro M; Rios DRA Ann Hematol; 2021 Feb; 100(2):375-382. PubMed ID: 33404693 [TBL] [Abstract][Full Text] [Related]
33. Imbalance of the von Willebrand Factor - ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S). Braune M; Metelmann M; de Fallois J; Pfrepper C; Barrantes-Freer A; Hiller GGR; Unger S; Seelow E; Halbritter J; Pelz JO Neurol Res Pract; 2024 Jun; 6(1):32. PubMed ID: 38898536 [TBL] [Abstract][Full Text] [Related]
34. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. Chen J; Hobbs WE; Le J; Lenting PJ; de Groot PG; López JA Blood; 2011 Mar; 117(13):3680-3. PubMed ID: 21300978 [TBL] [Abstract][Full Text] [Related]
35. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study. Koc A; Gumruk F; Gurgey A Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615 [TBL] [Abstract][Full Text] [Related]
36. Activation of the endogenous coagulation system in patients with atrial flutter: relationship to echocardiographic markers of thromboembolic risk. Kamath GS; Herweg B; Cotiga D; Pierce W; Cohen AJ; Chaudhry FA; Drejka ML; Steinberg JS Cardiol J; 2010; 17(4):390-6. PubMed ID: 20690096 [TBL] [Abstract][Full Text] [Related]
37. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention]. Jia XQ; Dong CM; Qin J; Zhang L Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576 [TBL] [Abstract][Full Text] [Related]
38. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Sosothikul D; Seksarn P; Pongsewalak S; Thisyakorn U; Lusher J Thromb Haemost; 2007 Apr; 97(4):627-34. PubMed ID: 17393026 [TBL] [Abstract][Full Text] [Related]